MSD
Pembrolizumab
Biodrugs/ Drugs
Cancer
Subcutaneous Pembrolizumab versus Intravenous Pembrolizumab administrated with Platinum doublet chemotherapy in Metastasic Squamous or Nonsquamous non small cell lung cancer
3Phase III in Spain,
2Phase II,
1Phase I